Show Summary Details
Page of

Asthma, Substance Abuse, and Tobacco Use: Comorbid and Coexisting 

Asthma, Substance Abuse, and Tobacco Use: Comorbid and Coexisting
Asthma, Substance Abuse, and Tobacco Use: Comorbid and Coexisting

Riccardo Polosa

and Pasquale Caponnetto

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 June 2021

This chapter presents a review of current knowledge of relationships between asthma and substance abuse, including marijuana, cocaine, heroin, tobacco, and alcohol. Asthma and other medical conditions are found at higher rates among patients with substance-related disorders. There is a growing body of evidence that patients with substance-related disorders may receive lower quality care for some medical conditions. Patients with substance-related disorders and persistent asthma fill prescriptions for controller medications at lower rates than patients without substance-related disorders. Whether these differences are due to differential access to care, decreased compliance with treatment recommendations, or the receipt of substandard care, these findings still may partially explain the disparities in asthma outcomes observed for these patients. An integrated approach could lead to effective treatment for these conditions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.